Scope Law advises the Swiss team of a fast-growing international specialty pharma company in in/out-licensing and IP-transfer agreement negotiations to develop, commercialize and distribute an innovative pharmaceutical products together with partners such as venture capital funds.
top of page
Recent Posts
See AllScope Law advises Perovskia Solar AG , Aubonne, a spin-off from the Swiss Federal Laboratories for Materials Science and Technology (...
Scope Law advises Crearene AG , Frauenfeld, Switzerland on further equity financing. Crearene, an innovative medical technology company...
Scope Law acts as Swiss legal counsel to the shareholders of Pharma-Data S.A. (Greece) on its sale to Rosemont Pharmaceuticals Ltd....
bottom of page
Hozzászólások